CEWG January 09 Full Report - National Institute on Drug Abuse

More documents

Recommendations

Info

Section IV. Across <strong>CEWG</strong> Areas: Treatment Admissions, Forensic Laboratory Analysis Data, and Average Drug Price and Purity Data 6.0 percent in Detroit and 3.8 percent in Texas to less than 1.0 percent in 10 of 22 areas reporting in the first half of 2008 (table 8). Buprenorphine and Methadone. Boston was the only <strong>CEWG</strong> area with at least 1 percent of drug items identified containing buprenorphine, while New York City was the only area reporting a percentage of 1 or higher for methadone drug items (table 8). In Boston, 274 drug items containing buprenorphine were identified, constituting 1.8 percent of all drug items identified in the first half of 2008. In New York City, 281 drug items containing methadone were identified in the period, representing 1.0 percent of all drug items identified (table 8). According to <strong>CEWG</strong> area reports reflected in table 1 (section II), buprenorphine ranked fifth in identified drugs in Boston, Baltimore City, and Maryland in the first half of 2008. Methadone ranked 6th in identified drugs in New York City, 7th in Baltimore City, 8th in Maryland, 9th in Boston and San Francisco, and 10th in Philadelphia during this reporting period. Table 7. Primary Other Opiates Treatment Admissions in 17 <strong>CEWG</strong> Areas as a Percentage of Total Admissions, Including and Excluding Primary Alcohol Admissions: 1H 2008 1 Primary Other Opiate Admissions Total Admissions with Primary Alcohol Admissions Excluded 3 Total Admissions with Primary Alcohol Admissions Included <strong>CEWG</strong> Areas 2 # # % # % 1H 2008 Atlanta 2<strong>09</strong> 2,789 7.5 4,242 4.9 Baltimore City 291 8,267 3.5 9,729 3.0 Boston 346 5,780 6.0 8,722 4.0 Colorado 557 8,286 6.7 13,953 4.0 Denver 239 3,860 6.2 6,<strong>09</strong>4 3.9 Detroit 58 2,965 2.0 4,<strong>09</strong>5 1.4 Los Angeles 586 22,260 2.6 27,944 2.1 Maine 1,915 3,623 52.9 6,444 29.7 Maryland 2,473 22,510 11.0 34,379 7.2 Minneapolis/ 521 4,713 11.1 9,846 5.3 St. Paul New York City 489 30,362 1.6 42,402 1.2 Philadelphia 71 5,785 1.2 7,422 1.0 Phoenix 51 1,352 3.8 2,028 2.5 San Diego 303 6,160 4.9 7,616 4.0 Seattle 292 4,522 6.5 7,067 4.1 St. Louis 118 4,129 2.9 6,248 1.9 Texas 2,638 33,212 7.9 44,983 5.9 1 Data are for the first half of 2008: <strong>January</strong>–June 2008. 2 Miami/Dade County data for FY 2008 and Cincinnati data for 1H 2008 combine heroin and other opiates; data are included in the heroin treatment admissions tables. 3 Percentages of primary other opiates admissions are obtained from admissions with primary alcohol admissions excluded for comparability with past data. SOURCE: <strong>January</strong> 20<strong>09</strong> State and local <strong>CEWG</strong> reports Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong> 85
EpidEmiologic TrEnds in drug AbusE: HigHligHTs And ExEcuTivE summAry Table 8. Selected Narcotic Analgesic Items <strong>Report</strong>ed by Forensic Laboratories in 22 <strong>CEWG</strong> Areas, by Number and Percentage of Total Items Identified 1 : 1H 2008 2 <strong>CEWG</strong> Oxycodone Hydrocodone Methadone Fentanyl Buprenorphine Total Areas # (%) # (%) # (%) # (%) # (%) Items Albuquerque 11 1.5 5 * 1 * 0 * 0 * 733 Atlanta 145 2.1 192 2.8 37 * 0 * 0 * 6,779 Baltimore City 274 1.0 50 * 107 * 0 * 265 * 28,288 Boston 6<strong>09</strong> 4.1 119 * 92 * 4 * 274 1.8 14,921 Chicago 32 * 202 * 39 * 1 * 29 * 40,400 Cincinnati 143 2.0 106 1.5 21 * 2 * 0 * 7,011 Denver 62 1.5 42 1.0 5 * 0 * 1 * 4,252 Detroit 44 1.2 210 6.0 14 * 0 * 3 * 3,527 Honolulu 13 1.1 7 * 6 * 0 * 0 * 1,143 Los Angeles 80 * 358 1.2 34 * 0 * 7 * 29,567 Maryland 366 1.1 76 * 116 * 1 * 284 * 33,219 Miami 111 * 38 * 11 * 0 * 4 * 16,015 Minneapolis/ 35 1.4 25 1.0 9 * 0 * 6 * 2,502 St. Paul New York City 277 1.0 228 * 281 1.0 0 * 79 * 27,064 Philadelphia 484 3.0 104 * 50 * 9 * 18 * 16,057 Phoenix 37 1.1 40 1.2 5 * 0 * 5 * 3,372 San Diego 83 * 179 1.7 25 * 1 * 15 * 10,234 San Francisco 273 2.3 240 2.0 93 * 6 * 5 * 11,925 Seattle 75 4.8 25 1.6 7 * 0 * 6 * 1,573 St. Louis 94 1.0 122 1.3 18 * 2 * 13 * 9,605 Texas 176 * 1,814 3.8 128 * 10 * 21 * 47,868 Washington, DC 21 * 1 * 3 * 0 * 5 * 2,3<strong>09</strong> 1 Only percentages of 1.0 or higher are reported in this table; percentages of less than 1.0 are indicated by the symbol *. 2 Data are for the first half of 2008: <strong>January</strong>–June 2008. SOURCE: All data were received from NFLIS, DEA, <strong>January</strong> 4, 20<strong>09</strong> (see appendix table 2); data are subject to change and may differ according to the date on which they were queried 86 Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong>
Page 1 and 2:
EpidEmiologic TrEnds in drug AbusE
Page 3 and 4:
EpidEmiologic TrEnds in drug AbusE:
Page 5 and 6:
Page 7 and 8:
Foreword Foreword This Executive Su
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
58.9 17.5 1.8 1.5 EpidEmiologic TrE
Page 37 and 38:
Page 39 and 40:
Page 41 and 42: EpidEmiologic TrEnds in drug AbusE:
Page 91: EpidEmiologic TrEnds in drug AbusE:
Page 115 and 116: Participant List Participant List <
Page 117 and 118: Participant List Daniel P. Dooley S
Page 119 and 120: Participant List John A. Newmeyer,
Page 121: NIH Publication No. 09</str
show all

CEWG January 09 Full Report - National Institute on Drug Abuse

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?